AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20061873 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy plus cognitive restructuring
Number of subjects: 54
Study 20061873 — intervention group
Group type: COMPARATOR
Intervention: Prolonged exposure therapy
Number of subjects: 54
Study 17345556 — intervention group
Group type: EXPERIMENTAL
Intervention: Idursulfase (0.5 mg/kg) administered weekly
Number of subjects: 96
Study 17345556 — intervention group
Group type: EXPERIMENTAL
Intervention: Idursulfase (0.5 mg/kg) administered fortnightly
Number of subjects: 96
Study 17345556 — intervention group
Group type: COMPARATOR
Intervention: Idursulfase (0.5 mg/kg)
Number of subjects: 96
Study 15857744 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Brief Pain Inventory (BPI-DPN)
Number of subjects: 255
Study 12066729 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal
Number of subjects: 180
Study 12066729 — intervention group
Group type: COMPARATOR
Intervention: Classic laryngeal mask airway
Number of subjects: 180
Study 9573910 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncertainty management intervention
Number of subjects: 403
Study 7706611 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn oil (CO)
Number of subjects: 12
Study 7706611 — intervention group
Group type: EXPERIMENTAL
Intervention: Beef tallow (BT)
Number of subjects: 12
Study 7706611 — intervention group
Group type: COMPARATOR
Intervention: Both fats (CO and BT)
Number of subjects: 12
Study 2198233 — intervention group
Group type: COMPARATOR
Intervention: Propranolol alone (20-80 mg)
Number of subjects: 34
Study 2198233 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol in combination with dilazep (50 mg three times a day)
Number of subjects: 34
Study 2198233 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of propranolol and dilazep
Number of subjects: 34
Study 346219 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (high-dose methotrexate, adriamycin, and vincristine)
Number of subjects: 32
Study 346219 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 32
Study 346219 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy
Number of subjects: 32
Study 30829668 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine at 0.25 µg/kg/min
Number of subjects: 80
Study 30829668 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine at 0.375 µg/kg/min
Number of subjects: 80
Study 30829668 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine at 0.5 µg/kg/min
Number of subjects: 80
Study 30829668 — intervention group
Group type: EXPERIMENTAL
Intervention: IV infusion of phenylephrine at 0.625 µg/kg/min
Number of subjects: 80
Study 30829668 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic phenylephrine infusion
Number of subjects: 80
Study 31526276 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ injury prevention program
Number of subjects: 1825
Study 31526276 — intervention group
Group type: COMPARATOR
Intervention: Usual warm-up routine (control)
Number of subjects: 1825
Study 27987236 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (100 mg orally)
Number of subjects: 9
Study 27987236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 26444161 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology (12 sessions)
Number of subjects: 45
Study 23589806 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools
Number of subjects: 1050
Study 23589806 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 1050
Study 21756566 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise treatment for shoulder pain (12-week at-home program)
Number of subjects: 58
Study 21756566 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 58
Study 19250705 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention
Number of subjects: 1493
Study 19250705 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1493
Study 16648775 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (20 Hz) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 16
Study 16648775 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 16
Study 15565935 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400microg) administered once daily via Turbuhaler
Number of subjects: 24
Study 15565935 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (400microg) administered twice daily via metered-dose inhaler
Number of subjects: 24
Study 11221554 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered treatment (CCT)
Number of subjects: 68
Study 11221554 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered treatment (CCT) with additional behavioral exposure treatment
Number of subjects: 68
Study 9290860 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol cues (valid and invalid); 2/3 of trials valid, 1/3 invalid; response target appeared after 100 or 500 milliseconds.
Number of subjects: 16
Study 8512828 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (30 mg m-2 weekly)
Number of subjects: 72
Study 8512828 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin (25 mg m-2 weekly)
Number of subjects: 72
Study 8512828 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin
Number of subjects: 72
Study 8512828 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 72
Study 2880017 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal doppler umbilical artery waveform studies
Number of subjects: 300
Study 2880017 — intervention group
Group type: COMPARATOR
Intervention: Control group (no doppler studies)
Number of subjects: 300
Study 30932950 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine-IR
Number of subjects: 42
Study 30932950 — intervention group
Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 42
Study 30412478 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy plus GPR program
Number of subjects: 60
Study 30412478 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF and conventional exercise therapy
Number of subjects: 60
Study 30412478 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 26475844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (1,000 mg daily for 10 weeks)
Number of subjects: 36
Study 26475844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 25107879 — intervention group
Group type: EXPERIMENTAL
Intervention: telcagepant 140 mg
Number of subjects: 660
Study 25107879 — intervention group
Group type: EXPERIMENTAL
Intervention: telcagepant 280 mg
Number of subjects: 660
Study 25107879 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 660
Study 21795293 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic lectures followed by skills workshop and simulated case scenario (lecture‐first)
Number of subjects: 98
Study 21795293 — intervention group
Group type: COMPARATOR
Intervention: Simulated case scenario followed by didactic lectures (simulation‐first)
Number of subjects: 98
Study 20485974 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group A used fluor protector every three months under dentist's guidance.
Number of subjects: 75
Study 20485974 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group B used Casein phosphopeptide amorphous calcium phosphate (CPP-ACP) once a day.
Number of subjects: 75
Study 20485974 — intervention group
Group type: COMPARATOR
Intervention: Control group emphasized on daily oral hygiene.
Number of subjects: 75
Study 17021598 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented soymilk (FS)
Number of subjects: 16
Study 17021598 — intervention group
Group type: COMPARATOR
Intervention: Non-fermented soymilk (NFS)
Number of subjects: 16
Study 16238982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy
Number of subjects: 490
Study 16238982 — intervention group
Group type: COMPARATOR
Intervention: No cardiac resynchronization therapy (Control)
Number of subjects: 490
Study 12074416 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.05% + fentanyl 0.00015%
Number of subjects: 40
Study 12074416 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.05% + fentanyl 0.00015%
Number of subjects: 40
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR at 10(8) CFU plus CVD 111 at 10(7) CFU
Number of subjects: 170
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR at 10(8) CFU plus CVD 111 at 10(6) CFU
Number of subjects: 170
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR alone at 10(8) CFU
Number of subjects: 170
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 111 alone at 10(7) CFU
Number of subjects: 170
Study 10085055 — intervention group
Group type: COMPARATOR
Intervention: inactivated Escherichia coli placebo
Number of subjects: 170
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR either alone or in combination
Number of subjects: 170
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 111
Number of subjects: 170
Study 10085055 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR and CVD 111 combination
Number of subjects: 170
Study 7845291 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise at 90% VO2max
Number of subjects: 12
Study 7845291 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise at 120% VO2max
Number of subjects: 12
Study 7845291 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive interval training sessions (10 days)
Number of subjects: 12
Study 7845291 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery period (6 days) after intensive interval training
Number of subjects: 12
Study 2219460 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic head Heaf gun
Number of subjects: 696
Study 2219460 — intervention group
Group type: COMPARATOR
Intervention: Fixed head gun
Number of subjects: 696
Study 342041 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g cephaloridine intraincisionally
Number of subjects: 209
Study 342041 — intervention group
Group type: COMPARATOR
Intervention: Irrigation with saline
Number of subjects: 209
Study 342041 — intervention group
Group type: COMPARATOR
Intervention: Povidone-iodine spraying
Number of subjects: 209
Study 342041 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk operations
Number of subjects: 209
Study 31119765 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 1: Four coaching sessions with an advanced practice nurse or social worker and four videoconference appointments during the oncologist-patient office visit.
Number of subjects: 332
Study 31119765 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 2: Four videoconference appointments with the oncologist and patient.
Number of subjects: 332
Study 31119765 — intervention group
Group type: COMPARATOR
Intervention: Arm 3: Control group receiving access to information through a website.
Number of subjects: 332
Study 27172269 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional‐based training group (TT; n = 11; 65‐75% of MAS, combined with 10‐12 repetition maximum [RM])
Number of subjects: 31
Study 27172269 — intervention group
Group type: EXPERIMENTAL
Intervention: Polarized training group (PT; n = 10; 35‐40% and 120% of MAS, combined with 5RM and 15RM)
Number of subjects: 31
Study 27172269 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG; n = 10)
Number of subjects: 31
Study 26346433 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture (WAA)
Number of subjects: 100
Study 26346433 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100
Study 24257429 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored educational intervention
Number of subjects: 1072
Study 24257429 — intervention group
Group type: COMPARATOR
Intervention: Usual/normal care control
Number of subjects: 1072
Study 21311759 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic activation of motor programs in the medial premotor cortex
Number of subjects: 0
Study 21311759 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal stimuli
Number of subjects: 0
Study 21311759 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual environmental settings
Number of subjects: 0
Study 19647066 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovalent HPV type 16 vaccine
Number of subjects: 290
Study 19647066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 290
Study 17268408 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of vegetables (400 g/day) and fruit (300 g/day) through a group-based behavioral program for 3 months
Number of subjects: 138
Study 17268408 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of vegetables and fruit
Number of subjects: 138
Study 17268408 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of vegetables
Number of subjects: 138
Study 15587230 — intervention group
Group type: EXPERIMENTAL
Intervention: Elated mood state (Velten procedure)
Number of subjects: 0
Study 15587230 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood state (Velten procedure)
Number of subjects: 0
Study 15587230 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral mood state (Velten procedure)
Number of subjects: 0
Study 15587230 — intervention group
Group type: EXPERIMENTAL
Intervention: Low arousal state (induced through physical exercise)
Number of subjects: 0
Study 15587230 — intervention group
Group type: EXPERIMENTAL
Intervention: High arousal state (induced through physical exercise)
Number of subjects: 0
Study 11573627 — intervention group
Group type: EXPERIMENTAL
Intervention: Alphadolone (25-500 mg, n = 9)
Number of subjects: 14
Study 11573627 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose, n = 5)
Number of subjects: 14
Study 9626375 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral loading dose of carbamazepine 8 mg/kg in suspension form
Number of subjects: 6
Study 9626375 — intervention group
Group type: COMPARATOR
Intervention: Oral loading dose of carbamazepine 8 mg/kg in tablet form
Number of subjects: 6
Study 9626375 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations (tablet and suspension)
Number of subjects: 6
Study 7871774 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiatherosclerotic diet with polyunsaturated fatty acids omega 3
Number of subjects: 112
Study 7871774 — intervention group
Group type: COMPARATOR
Intervention: Antiatherosclerotic diet without omega 3
Number of subjects: 112
Study 2899237 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine at 10 mg/kg for two doses
Number of subjects: 106
Study 2899237 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine at 8 mg/kg for three doses
Number of subjects: 106
Study 30130144 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week Iyengar Yoga intervention given twice weekly
Number of subjects: 0
Study 30130144 — intervention group
Group type: COMPARATOR
Intervention: Twice-weekly 12-week program of traditional exercise (e.g., walking, stationary cycling)
Number of subjects: 0
Study 28587568 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase treatment
Number of subjects: 39
Study 28587568 — intervention group
Group type: COMPARATOR
Intervention: Needle fasciotomy
Number of subjects: 39
Study 25683775 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-combustion inhaler type of tobacco product (NCIT)
Number of subjects: 80
Study 25683775 — intervention group
Group type: COMPARATOR
Intervention: Conventional cigarette (CC1)
Number of subjects: 80
Study 25683775 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers (NS)
Number of subjects: 80
Study 23170990 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemigliptin 50 mg
Number of subjects: 182
Study 23170990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 21600058 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program and regular phone coaching to increase physical activity
Number of subjects: 0
Study 21600058 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 18641545 — intervention group
Group type: COMPARATOR
Intervention: 20 mg synthetic tetrahydrocannabinol (Marinol)
Number of subjects: 18
Study 18641545 — intervention group
Group type: EXPERIMENTAL
Intervention: five different types of Cannabis sativa extracts
Number of subjects: 18
Study 16463153 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (MTX) infusion regimens (4-h vs 24-h infusion)
Number of subjects: 484
Study 16463153 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX applied as 24-h infusion in all patients with lymphoblastic lymphoma and anaplastic large cell lymphoma
Number of subjects: 484
Study 16463153 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR 677 C-->T polymorphism
Number of subjects: 484
Study 14620893 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyst size of 2.4 mm (SE, 0.2 mm) for 13 to 21 weeks' gestation
Number of subjects: 166
Study 14620893 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyst size of 1.9 mm (SE, 0.17 mm) for 22 to 38 weeks' gestation
Number of subjects: 166
Study 14620893 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture analysis
Number of subjects: 166
Study 14620893 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analysis
Number of subjects: 166
Study 14620893 — intervention group
Group type: EXPERIMENTAL
Intervention: Interobserver and intraobserver kappa statistics
Number of subjects: 166
Study 10897230 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation with physician
Number of subjects: 318
Study 10897230 — intervention group
Group type: COMPARATOR
Intervention: Self-treatment (not consulting a physician)
Number of subjects: 318
Study 10897230 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-employed patients
Number of subjects: 318
Study 8636549 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated tissue-type plasminogen activator (t-PA)
Number of subjects: 0
Study 8636549 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 0
Study 8636549 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation delay < 1 hour
Number of subjects: 0
Study 8636549 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation delay > 4 hours
Number of subjects: 0
Study 8636549 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment delay < 1 hour
Number of subjects: 0
Study 8636549 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment delay > 90 minutes
Number of subjects: 0
Study 8636549 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to treatment increase
Number of subjects: 0
Study 1614041 — intervention group
Group type: EXPERIMENTAL
Intervention: High osmolar contrast
Number of subjects: 249
Study 1614041 — intervention group
Group type: COMPARATOR
Intervention: Low osmolar contrast
Number of subjects: 249
Study 6487076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ban on sexual intercourse and communication of sexual preferences
Number of subjects: 16
Study 6487076 — intervention group
Group type: COMPARATOR
Intervention: Communication of sexual preferences only
Number of subjects: 16
Study 30773968 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag as monotherapy (Arm A); starting dose 200 mg orally daily
Number of subjects: 29
Study 30773968 — intervention group
Group type: COMPARATOR
Intervention: Continuation of HMA (Arm B)
Number of subjects: 29
Study 28914713 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfibrinolytic (HF) phenotype
Number of subjects: 680
Study 28914713 — intervention group
Group type: COMPARATOR
Intervention: Shutdown (SD) phenotype
Number of subjects: 680
Study 28914713 — intervention group
Group type: COMPARATOR
Intervention: Physiologic (PHYS) phenotype
Number of subjects: 680
Study 26490015 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician education and audit/feedback on antibiotic prescribing quantity and quality
Number of subjects: 88
Study 26490015 — intervention group
Group type: COMPARATOR
Intervention: Control practices (no intervention)
Number of subjects: 88
Study 24606090 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg PVI once daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg PVI once daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg PVI once daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg PVI twice daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg PVI twice daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: COMPARATOR
Intervention: 50 mg PIO via im injection once daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: COMPARATOR
Intervention: 100 mg PIO via im injection once daily
Number of subjects: 58
Study 24606090 — intervention group
Group type: COMPARATOR
Intervention: 200 mg PIO via im injection once daily
Number of subjects: 58
Study 22313739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger (1.5 g/d in 3 divided doses every 8 hours) plus standard antiemetic regimen (granisetron plus dexamethasone)
Number of subjects: 100
Study 22313739 — intervention group
Group type: COMPARATOR
Intervention: Standard antiemetic regimen (granisetron plus dexamethasone)
Number of subjects: 100
Study 20809807 — intervention group
Group type: EXPERIMENTAL
Intervention: Difluprednate 0.05% (Durezol) 4x/day (n=50)
Number of subjects: 90
Study 20809807 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1% (Pred Forte) 8x/day (n=40)
Number of subjects: 90
Study 17684881 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus intravenous hydrocortisone (200 mg first, then 100 mg TID for 48 hours)
Number of subjects: 60
Study 17684881 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (complete bed rest, hydration, acetaminophen and pethidine)
Number of subjects: 60
Study 16124967 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique 2 (leg into extension while maintaining internal rotation after insertion of the femoral component)
Number of subjects: 19